These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

530 related articles for article (PubMed ID: 19783716)

  • 61. Evidence for unfolded protein response activation in monocytes from individuals with alpha-1 antitrypsin deficiency.
    Carroll TP; Greene CM; O'Connor CA; Nolan AM; O'Neill SJ; McElvaney NG
    J Immunol; 2010 Apr; 184(8):4538-46. PubMed ID: 20228200
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Heterozygous alpha-I antitrypsin deficiency as a co-factor in the development of chronic liver disease: a review.
    Kok KF; Wahab PJ; Houwen RH; Drenth JP; de Man RA; van Hoek B; Meijer JW; Willekens FL; de Vries RA
    Neth J Med; 2007 May; 65(5):160-6. PubMed ID: 17519511
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Alpha-1-antitrypsin and other proteinase inhibitors.
    Miravitlles M
    Curr Opin Pharmacol; 2012 Jun; 12(3):309-14. PubMed ID: 22365503
    [TBL] [Abstract][Full Text] [Related]  

  • 64. A polymorphism of the alpha1-antitrypsin gene represents a risk factor for liver disease.
    Chappell S; Hadzic N; Stockley R; Guetta-Baranes T; Morgan K; Kalsheker N
    Hepatology; 2008 Jan; 47(1):127-32. PubMed ID: 17972336
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Molecular characterisation of the defective alpha 1-antitrypsin alleles PI Mwurzburg (Pro369Ser), Mheerlen (Pro369Leu), and Q0lisbon (Thr68Ile).
    Poller W; Merklein F; Schneider-Rasp S; Haack A; Fechner H; Wang H; Anagnostopoulos I; Weidinger S
    Eur J Hum Genet; 1999 Apr; 7(3):321-31. PubMed ID: 10234508
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Recombinant human alpha-1 proteinase inhibitor: towards therapeutic use.
    Karnaukhova E; Ophir Y; Golding B
    Amino Acids; 2006 Jun; 30(4):317-32. PubMed ID: 16773239
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Pathogenesis of COPD. Part I. The role of protease-antiprotease imbalance in emphysema.
    Abboud RT; Vimalanathan S
    Int J Tuberc Lung Dis; 2008 Apr; 12(4):361-7. PubMed ID: 18371259
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Alpha-1 antitrypsin Null mutations and severity of emphysema.
    Fregonese L; Stolk J; Frants RR; Veldhuisen B
    Respir Med; 2008 Jun; 102(6):876-84. PubMed ID: 18353624
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Activity of the alpha-1 antitrypsin deficiency registry in Belgium.
    Hutsebaut J; Janssens W; Louis R; Willersinn F; Stephenne X; Sokal E; Derom E
    COPD; 2015 May; 12 Suppl 1():10-4. PubMed ID: 25938285
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Serum levels and genotype distribution of α1-antitrypsin in the general population.
    Ferrarotti I; Thun GA; Zorzetto M; Ottaviani S; Imboden M; Schindler C; von Eckardstein A; Rohrer L; Rochat T; Russi EW; Probst-Hensch NM; Luisetti M
    Thorax; 2012 Aug; 67(8):669-74. PubMed ID: 22426792
    [TBL] [Abstract][Full Text] [Related]  

  • 71. A review of alpha-1 antitrypsin deficiency.
    Ioachimescu OC; Stoller JK
    COPD; 2005 Jun; 2(2):263-75. PubMed ID: 17136953
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Association of moderate alpha-1 antitrypsin deficiency with lung cancer in the Serbian population.
    Topic AS; Jelic-Ivanovic ZD; Spasojevic-Kalimanovska VV; Spasic SM
    Arch Med Res; 2006 Oct; 37(7):866-70. PubMed ID: 16971227
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Therapeutic level of functional human alpha 1 antitrypsin (hAAT) secreted from murine muscle transduced by adeno-associated virus (rAAV1) vector.
    Lu Y; Choi YK; Campbell-Thompson M; Li C; Tang Q; Crawford JM; Flotte TR; Song S
    J Gene Med; 2006 Jun; 8(6):730-5. PubMed ID: 16518879
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Alpha1-antitrypsin deficiency-associated panniculitis: case report and review of treatment options.
    Ortiz PG; Skov BG; Benfeldt E
    J Eur Acad Dermatol Venereol; 2005 Jul; 19(4):487-90. PubMed ID: 15987301
    [TBL] [Abstract][Full Text] [Related]  

  • 75. The pallid mouse. A model of genetic alpha 1-antitrypsin deficiency.
    Martorana PA; Brand T; Gardi C; van Even P; de Santi MM; Calzoni P; Marcolongo P; Lungarella G
    Lab Invest; 1993 Feb; 68(2):233-41. PubMed ID: 8441253
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Alpha-1-antitrypsin deficiency.
    Perlmutter DH
    Semin Liver Dis; 1998; 18(3):217-25. PubMed ID: 9773422
    [TBL] [Abstract][Full Text] [Related]  

  • 77. The effects of weekly augmentation therapy in patients with PiZZ α1-antitrypsin deficiency.
    Schmid ST; Koepke J; Dresel M; Hattesohl A; Frenzel E; Perez J; Lomas DA; Miranda E; Greulich T; Noeske S; Wencker M; Teschler H; Vogelmeier C; Janciauskiene S; Koczulla AR
    Int J Chron Obstruct Pulmon Dis; 2012; 7():687-96. PubMed ID: 23055718
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Z-type alpha 1-antitrypsin is less competent than M1-type alpha 1-antitrypsin as an inhibitor of neutrophil elastase.
    Ogushi F; Fells GA; Hubbard RC; Straus SD; Crystal RG
    J Clin Invest; 1987 Nov; 80(5):1366-74. PubMed ID: 3500183
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Diagnosis and treatment of lung disease associated with alpha one-antitrypsin deficiency: A position statement from the Thoracic Society of Australia and New Zealand.
    Dummer J; Dobler CC; Holmes M; Chambers D; Yang IA; Parkin L; Smith S; Wark P; Dev A; Hodge S; Dabscheck E; Gooi J; Samuel S; Knowles S; Holland AE
    Respirology; 2020 Mar; 25(3):321-335. PubMed ID: 32030868
    [TBL] [Abstract][Full Text] [Related]  

  • 80. [Clinical consequences and diagnosis of congenital alpha 1-antitrypsin deficiency].
    Lipska A; Wysocka J
    Przegl Lek; 1998; 55(10):537-41. PubMed ID: 10224869
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 27.